200 related articles for article (PubMed ID: 12452870)
1. Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: results of a validation study.
Housman TS; Patel MJ; Camacho F; Feldman SR; Fleischer AB; Balkrishnan R
Br J Dermatol; 2002 Dec; 147(6):1192-8. PubMed ID: 12452870
[TBL] [Abstract][Full Text] [Related]
2. The Self-administered Eczema Area and Severity Index in children with moderate to severe atopic dermatitis: better estimation of AD body surface area than severity.
van Velsen SG; Knol MJ; Haeck IM; Bruijnzeel-Koomen CA; Pasmans SG
Pediatr Dermatol; 2010; 27(5):470-5. PubMed ID: 20796235
[TBL] [Abstract][Full Text] [Related]
3. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis.
Chopra R; Vakharia PP; Sacotte R; Patel N; Immaneni S; White T; Kantor R; Hsu DY; Silverberg JI
Br J Dermatol; 2017 Nov; 177(5):1316-1321. PubMed ID: 28485036
[TBL] [Abstract][Full Text] [Related]
4. Validation of remote atopic dermatitis severity assessment with the Eczema Area and Severity Ondex in children using caregiver-provided photos and videos.
Croce EA; Rathouz PJ; Lopes FCPS; Leszczynska M; Diaz LZ; Levy ML; Ruth JS; Varshney P; Rew L; Matsui EC
Pediatr Dermatol; 2022 Jul; 39(4):547-552. PubMed ID: 35522088
[TBL] [Abstract][Full Text] [Related]
5. Disease severity and associated family impact in childhood atopic dermatitis.
Balkrishnan R; Housman TS; Carroll C; Feldman SR; Fleischer AB
Arch Dis Child; 2003 May; 88(5):423-7. PubMed ID: 12716715
[TBL] [Abstract][Full Text] [Related]
6. Remote severity assessment in atopic dermatitis: Validity and reliability of the remote Eczema Area and Severity Index and Self-Administered Eczema Area and Severity Index.
Ragamin A; Schappin R; Tan Nguyen N; Nouwen AEM; Hoekstra LF; Schuttelaar MLA; Pasmans SGMA
JAAD Int; 2023 Dec; 13():184-191. PubMed ID: 38025299
[TBL] [Abstract][Full Text] [Related]
7. What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study.
Leshem YA; Hajar T; Hanifin JM; Simpson EL
Br J Dermatol; 2015; 172(5):1353-7. PubMed ID: 25580670
[TBL] [Abstract][Full Text] [Related]
8. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group.
Hanifin JM; Thurston M; Omoto M; Cherill R; Tofte SJ; Graeber M
Exp Dermatol; 2001 Feb; 10(1):11-8. PubMed ID: 11168575
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme.
Barbier N; Paul C; Luger T; Allen R; De Prost Y; Papp K; Eichenfield LF; Cherill R; Hanifin J
Br J Dermatol; 2004 Jan; 150(1):96-102. PubMed ID: 14746622
[TBL] [Abstract][Full Text] [Related]
10. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation.
Schmitt J; Langan S; Deckert S; Svensson A; von Kobyletzki L; Thomas K; Spuls P;
J Allergy Clin Immunol; 2013 Dec; 132(6):1337-47. PubMed ID: 24035157
[TBL] [Abstract][Full Text] [Related]
11. Atopic Dermatitis in Children in the General Population: Baseline Characteristics, Medication Use, and Severity Measures in the Rotterdam Eczema Study.
van Halewijn KF; van der Most F; Bohnen AM; Pasmans SGMA; Bindels PJE; Elshout G
Dermatitis; 2024; 35(1):61-69. PubMed ID: 37015063
[No Abstract] [Full Text] [Related]
12. Product of Investigator Global Assessment and Body Surface Area (IGAxBSA): A practice-friendly alternative to the Eczema Area and Severity Index to assess atopic dermatitis severity in children.
Suh TP; Ramachandran D; Patel V; Jackson KL; Rangel SM; Fishbein AB; Paller AS
J Am Acad Dermatol; 2020 May; 82(5):1187-1194. PubMed ID: 31972257
[TBL] [Abstract][Full Text] [Related]
13. Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life.
Coutanceau C; Stalder JF
Dermatology; 2014; 229(3):248-55. PubMed ID: 25196258
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review.
Gerbens LA; Prinsen CA; Chalmers JR; Drucker AM; von Kobyletzki LB; Limpens J; Nankervis H; Svensson Å; Terwee CB; Zhang J; Apfelbacher CJ; Spuls PI;
Allergy; 2017 Jan; 72(1):146-163. PubMed ID: 27322918
[TBL] [Abstract][Full Text] [Related]
15. Dermatology Quality of Life Index scores in Bangladeshi patients with atopic eczema and their families in East London.
Tawfik SS; Thomas BR; Kelsell DP; Grigg J; O'Toole EA
Br J Dermatol; 2023 Mar; 188(4):524-532. PubMed ID: 36745558
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGA.
Bożek A; Reich A
Dermatology; 2017; 233(1):16-22. PubMed ID: 28494438
[TBL] [Abstract][Full Text] [Related]
17. What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis in clinical practice? A prospective observational study.
Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY
Br J Dermatol; 2021 May; 184(5):888-895. PubMed ID: 32959390
[TBL] [Abstract][Full Text] [Related]
18. Severity scoring of atopic dermatitis: a comparison of two scoring systems.
Rullo VE; Segato A; Kirsh A; Sole D
Allergol Immunopathol (Madr); 2008; 36(4):205-11. PubMed ID: 18928687
[TBL] [Abstract][Full Text] [Related]
19. A pilot comparison study of four clinician-rated atopic dermatitis severity scales.
Zhao CY; Tran AQ; Lazo-Dizon JP; Kim J; Daniel BS; Venugopal SS; Rhodes LM; Law MG; Murrell DF
Br J Dermatol; 2015 Aug; 173(2):488-97. PubMed ID: 25891151
[TBL] [Abstract][Full Text] [Related]
20. Validation of patient-reported global severity of atopic dermatitis in adults.
Vakharia PP; Chopra R; Sacotte R; Patel N; Immaneni S; White T; Kantor R; Hsu DY; Silverberg JI
Allergy; 2018 Feb; 73(2):451-458. PubMed ID: 28905999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
